AI-Powered Workflow for Auto-Populating Case Narratives from Unstructured Data

Medical writers currently spend hours collating and synthesizing data from PDFs, scanned records, and lab reports. This workflow automates that synthesis using a Retrieval-Augmented Generation (RAG) pipeline, where an LLM agent retrieves relevant facts from source documents and structures them into a chronological, medically coherent narrative. The primary savings is direct labor reduction, freeing senior staff for higher-value causality assessment and medical review.

Manual drafting leads to variability in style, detail, and emphasis, which can introduce risk during audits. This workflow enforces template adherence and standardized medical terminology (e.g., MedDRA, WHO-DD) through structured prompts and validation agents. It produces narratives that are consistently formatted, factually aligned with source documents, and audit-ready, reducing QC rework and strengthening regulatory posture.

The narrative drafting step is often on the critical path for case finalization and regulatory submission (e.g., 7/15-day clocks). By generating a draft narrative in minutes instead of days, this workflow compresses the overall case processing timeline. This directly impacts compliance metrics by reducing the risk of late reports and enables faster signal detection by getting validated cases into aggregate analysis sooner.

As product portfolios and data volumes grow, manual narrative writing creates a scalability ceiling. This automated workflow acts as a force multiplier, allowing existing PV teams to handle a 2-3x increase in case volume without proportional hiring. The operational upside is improved margin on safety operations and the ability to support more products or indications with the same core team.

The production architecture is not just an LLM call. It's a multi-step orchestrated workflow (built with LangGraph or similar) that includes: 1) Document Ingestion & Chunking (from Veeva Vault, SharePoint), 2) Fact Extraction & Temporal Sequencing, 3) Narrative Generation with strict prompt templates, 4) Automated Fact-Checking against source snippets, and 5) Routing to a Medical Reviewer for approval/modification in the safety database (e.g., ARISg, Oracle Argus).

Successful deployment follows a risk-aware, phased approach. Phase 1: Pilot on a single product's historical cases to tune prompts and measure accuracy against gold-standard narratives. Phase 2: Shadow mode in production, where the AI generates drafts in parallel with writers for comparison and refinement. Phase 3: Controlled go-live with a mandatory medical reviewer approval gate and continuous monitoring of edit rates and reviewer feedback to ensure safety and quality are never compromised.

This agent orchestrates the secure intake of unstructured source documents—scanned medical records, lab PDFs, physician correspondence—from email, fax servers, and EMR feeds. It performs OCR, de-identification (PHI redaction), and chunks text for downstream processing. Integration with legacy safety databases (e.g., Oracle Argus, Veeva Safety) ensures each document is linked to the correct case file.

The core reasoning layer. It queries a vector store of historical narratives, approved product labeling, and MedDRA/WHO-DD dictionaries to ground the LLM's output. Using a structured prompt, it extracts patient demographics, drug timelines, medical history, and event details from the chunked documents, synthesizing them into a chronological, factually consistent draft narrative. This replaces manual copy-paste and summarization.

An automated quality gate. This agent cross-references the draft narrative against the original source documents and structured case data (e.g., CIOMS form fields) to flag inconsistencies, missing temporality, or unsupported inferences. It scores the draft for completeness and accuracy, routing low-confidence outputs to a correction queue before medical review. This ensures the AI output is verifiable and audit-ready.

The critical human-in-the-loop control. The validated draft is presented to a qualified pharmacovigilance associate or physician in a review interface within the case processing system (e.g., ARISg). They can edit, approve, or reject the narrative. All changes, approvals, and the identity of the reviewer are captured in an immutable audit trail, satisfying 21 CFR Part 11 and GVP requirements for regulated document authorship.

The central nervous system of the workflow. Using a framework like LangGraph, it manages the state of each case as it moves through ingestion, RAG, validation, and review. It handles conditional routing (e.g., sending failed validations back to the correction queue), manages API calls to safety databases, and ensures idempotency. This provides visibility into pipeline health and allows for rollback if needed.

The production connective tissue. This involves containerized microservices (often via Azure/AWS/GCP) for each agent, secure REST/GraphQL APIs for communication with the core safety database and EMR systems, and a CI/CD pipeline for controlled updates. Observability is built in with logging (Datadog, Splunk) for performance metrics, error tracking, and to support periodic system validation required for GxP environments.

The core technical component is a RAG pipeline that retrieves relevant, chronologically ordered facts from fragmented source documents (EMRs, lab reports, correspondence) before synthesis. This prevents LLM hallucination by grounding the narrative in extracted evidence. Implementation requires chunking strategies, a vector database for semantic search, and a re-ranking step to ensure temporal coherence, all integrated upstream from the safety database (e.g., ARISg, Argus).

Automation does not replace medical review; it requires a hardened approval loop. The workflow must generate a draft narrative with highlighted source citations, route it to a qualified reviewer via the case management system, and capture all changes with a full audit trail. The system must support side-by-side comparison, reviewer comments, and version control to satisfy regulatory requirements for traceability and accountability in the narrative's final form.

Narratives must adhere to internal SOPs and regulatory expectations (e.g., ICH E2B R3 structure). The workflow enforces this through structured prompts and post-generation validation agents that check for required sections (patient history, event description, outcome), consistent terminology, and correct formatting. This eliminates stylistic variance and ensures every automated draft is submission-ready, reducing back-and-forth during quality control.

Not all source data is clear. The architecture must include confidence scoring for extracted facts and generated text. Low-confidence segments or contradictory evidence must be automatically flagged and routed to a human data associate for clarification via a dedicated queue within the PV workflow. This ensures automation scales handle while preserving data integrity for the 15-20% of cases that require human judgment.

The workflow's value is locked behind its integrations. It must connect bidirectionally with the core safety database for case context and to write back the final narrative. It also needs read access to clinical data warehouses, EMRs via FHIR/HL7, and document management systems. Using an orchestration layer like LangGraph to manage state and API calls across these heterogeneous systems is critical for a maintainable, observable implementation.

Deploying an LLM-based workflow is not a one-time event. It requires a continuous validation framework: tracking narrative quality metrics (e.g., reviewer acceptance rate, edit distance), monitoring for concept drift in source data, and maintaining a golden set of test cases. A model governance process is needed to approve prompt changes, retrain retrieval models, and document performance for internal audits and regulatory inquiries.